139 related articles for article (PubMed ID: 2737852)
1. CA 125 as a tumour marker in epithelial ovarian cancer.
Sheehan JD; Duffy MJ; Allen MA; Fennelly JJ
Ir J Med Sci; 1989 Jan; 158(1):10-3. PubMed ID: 2737852
[TBL] [Abstract][Full Text] [Related]
2. CA 125 in ovarian cancer.
van der Burg ME; Lammes FB; Verweij J
Neth J Med; 1992 Feb; 40(1-2):36-51. PubMed ID: 1579185
[TBL] [Abstract][Full Text] [Related]
3. What do CA 125 and other antigens tell us about ovarian cancer biology?
Welander CE
Acta Obstet Gynecol Scand Suppl; 1992; 155():85-93. PubMed ID: 1502896
[TBL] [Abstract][Full Text] [Related]
4. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
[TBL] [Abstract][Full Text] [Related]
5. [The value of CA 125 determination in the serum of patients with ovarian cancer].
Bartel U; Johannsen B; Elling D
Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma.
Hasholzner U; Baumgartner L; Stieber P; Meier W; Reiter W; Pahl H; Fateh-Moghadam A
Int J Cancer; 1996 Aug; 69(4):329-34. PubMed ID: 8797878
[TBL] [Abstract][Full Text] [Related]
7. The role of the CA 125 assay in the management of ovarian cancer.
Niloff JM
Oncology (Williston Park); 1988 Aug; 2(8):67-76. PubMed ID: 3275060
[TBL] [Abstract][Full Text] [Related]
8. [Significance of tumor-associated CA-125 antigen in the diagnosis and monitoring of ovarian cancer].
Ial'chenko NA; Levik NN; Musin II
Akush Ginekol (Mosk); 1991 Sep; (9):61-2. PubMed ID: 1746705
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
10. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
Miladinović D; Paunović R; Paunković N
Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer.
Teeling M; McGing P; Carney DN
Ir J Med Sci; 1989 Mar; 158(3):59-62. PubMed ID: 2745033
[TBL] [Abstract][Full Text] [Related]
12. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
[TBL] [Abstract][Full Text] [Related]
13. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
Plante M; Wong GY; Nisselbaum JS; Almadrones L; Hoskins WJ; Rubin SC
Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
[TBL] [Abstract][Full Text] [Related]
14. The value of CA 125 and CA72-4 in management of patients with epithelial ovarian cancer.
Fayed ST; Ahmad SM; Kassim SK; Khalifa A
Dis Markers; 1998 Nov; 14(3):155-60. PubMed ID: 10427474
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation.
Wilder JL; Pavlik E; Straughn JM; Kirby T; Higgins RV; DePriest PD; Ueland FR; Kryscio RJ; Whitley RJ; Nagell Jv
Gynecol Oncol; 2003 May; 89(2):233-5. PubMed ID: 12713985
[TBL] [Abstract][Full Text] [Related]
16. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
17. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas.
Molina R; Ojeda B; Filella X; Borras G; Jo J; Mas E; Lopez JJ; Ballesta A
Tumour Biol; 1992; 13(5-6):278-86. PubMed ID: 1290025
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer. CA 125 as a tumor marker. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Kaesemann H; Caffier H; Hoffmann FJ; Crombach G; Würz H; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G
Klin Wochenschr; 1986 Sep; 64(17):781-5. PubMed ID: 3463828
[TBL] [Abstract][Full Text] [Related]
20. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL
Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
